Aramark (NYSE: ARMK) officer reports new shares from dividend equivalents

Rhea-AI Filing Summary

Aramark executive vice president and chief human resources officer reported a routine increase in ownership of company stock through dividend-related awards. On 12/17/2025, the officer acquired 149.979 shares of Aramark common stock at a price of $0 per share. These shares reflect dividend equivalent rights credited on previously granted restricted stock units and performance stock units tied to the issuer’s quarterly dividend. After this transaction, the officer beneficially owns 81,322.513 shares of Aramark common stock in direct ownership. The dividend equivalent rights vest on the same schedules as the underlying equity awards.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Charpentier Abigail

(Last) (First) (Middle)

ARAMARK

2400 MARKET STREET

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief HR Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/17/2025		A		149.979(1)	A	$0	81,322.513	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on restricted stock units and previously granted performance stock units that were determined to be earned held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

Remarks:

	/s/ Ryan S. Spengler, as Attorney-in-fact	12/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Aramark (ARMK) report in this filing?

The filing reports that Aramark's executive vice president and chief human resources officer acquired 149.979 shares of common stock on 12/17/2025 through dividend equivalent rights at a price of $0 per share.

Who is the reporting person in this Aramark (ARMK) Form 4 and what is their role?

The reporting person is an officer of Aramark, serving as EVP & Chief HR Officer, and is disclosing changes in their beneficial ownership of Aramark common stock.

How many Aramark (ARMK) shares does the officer own after this transaction?

Following the reported transaction, the officer beneficially owns 81,322.513 shares of Aramark common stock in direct ownership.

What is the nature of the 149.979 Aramark (ARMK) shares acquired?

The 149.979 shares represent dividend equivalent rights accrued on restricted stock units and previously granted performance stock units in connection with Aramark's quarterly dividend.

Do the dividend equivalent rights for Aramark (ARMK) vest immediately?

No. The filing states that these dividend equivalent rights vest on the same schedules as the underlying restricted stock unit and performance stock unit awards.

Was there any cash paid for the Aramark (ARMK) shares acquired in this transaction?

No cash was paid. The 149.979 shares were acquired at a price of $0 per share as dividend equivalent rights.